Altium Capital Management LLC / CTNM
Altium Capital Management LLC’s Contineum Therapeutics Inc Position
Does Altium Capital Management LLC own Contineum Therapeutics Inc (CTNM)? Not currently — the last reported position was 303.9K shares worth $2M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$2M
Q1 2025
Shares
303.9K
% of Portfolio
+5.11%
Quarters Held
4
position exited
Position History CTNM
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of CTNM.